Multiple myeloma is a malignant plasma cell disorder characterized by clonal proliferation of abnormal plasma cells. Global five-year survival rates range from 60% to 70%, largely due to novel therapeutic strategies. In our country, conventional therapies remain standard, with monoclonal antibodies recently introduced for relapsed/refractory cases....

By Dragana Drašković, Goran Marjanović, Miodrag Vučić, Irena Ćojbašić

Introduction/Aim. Hemophilia A is an antihemophilic factor deficiency which requires life-long treatment. The aim of this analysis was to present the effects of prophylactic non-factor replacement therapy in ten patients with hemophilia A. Patients and methods. This retrospective analysis was conducted on ten male patients (4 children, 1 adolescent...

By Miodrag Vučić, Božidar Lilić, Danijela Jovančić-Petković, Jelena Vučić